Background: Evidence hints at the ability of b-cells to emerge from non-b-cells upon genetic or pharmacological interventions. However, their quantitative contributions to the process of autonomous b-cell regeneration without genetic or pharmacological manipulations remain to be determined.
INTRODUCTION
Both type 1 and type 2 diabetes can be attributed to a failure of insulinproducing b-cells. For the development of regenerative therapies, the reconstitution of b-cell mass under metabolically challenging conditions has therefore attracted great research interest. Initial lineage tracing studies concluded that self-replication accounts for nearly all of the turnover and regeneration of adult b-cells [1, 2] . Other investigators reported non-b-cell precursors for adult b-cells in specific contexts, such as pancreatic duct ligation [3e5], pregnancy [6] , extreme b-cell ablation [7, 8] , or induced differentiation [9e15] . The concept of interconversion of different pancreatic cell types is emerging, but its quantitative contribution to the cell-autonomous process, i.e. without any genetic or pharmacological manipulations, of b-cells turnover upon metabolic challenges remains largely unknown. Furthermore, most of these studies used the tamoxifen-inducible CreER/loxP system to label specific pools of cells in a temporally controlled manner.
However, recent observations have cast doubt on the ability of temporal control of gene expression/elimination with tamoxifen [16] . In adipocytes, the residual tamoxifen enables nuclear translocation of the CreER recombinase beyond two months of a washout period, along with significant metabolic side effects due to the pharmacological nature of tamoxifen as an estrogen receptor antagonist [17] . It is therefore essential to gain a better understanding of the actions of tamoxifen in the context of b-cell lineage tracing studies, compare it to other systems, and re-visit the data interpretation if necessary. As an alternative, the doxycycline-inducible system has proven to generate reliable lineage tracing results in adipose tissue, with fewer side effects and better temporal control on Cre recombinase activity [17, 18] .
As a common strategy for regenerative studies, b-cell ablation can be induced in adult rodents through a variety of methods, including pancreatectomy, pancreatic duct ligation, and administration of streptozotocin, alloxan, targeted delivery of diphtheria toxin, or targeted mutations in critical genes [19] . These approaches have disadvantages such as unspecific ablation [20] , poor control over the extent of the ablation, unspecific toxicity, limited regenerative capacity post ablation [21] , or irreversibly impaired functionality or viability of surviving b-cells. In contrast, the PANIC-ATTAC ("pancreatic islet bcell apoptosis through targeted activation of caspase 8") transgenic mouse has been characterized as a model of inducible, titratable, acute b-cell apoptosis [22, 23] . Administration of a chemical dimerizer, which is nontoxic and has a short half-life of around 5 h in mice, activates the intracellular apoptosis signaling in b-cells. In adult mice, the dimerizer-induced b-cell death peaks by 2 weeks post treatment, without any detectable inflammation (F4/80 or CD3 immunostaining, data not shown) or other side effects. More importantly, a moderate ablation, as indicated by a peak fed blood glucose level of 250e 600 mg/dL accompanied by 50e75% b-cell loss, allows for autonomous recovery of b-cell mass and blood glucose by 10 weeks post treatment.
Here, we utilized the PANIC-ATTAC model to trace the regenerated bcells with a tamoxifen-inducible labeling system. After a short washout of 1 week, the nuclear Cre was sustained by the residual tamoxifen activity and labeled most of the insulin þ cells during the chase phase.
In contrast, a much more extensive washout period of 4 months revealed w20% b-cells with a non-b-cell origin. This was further confirmed independently with a doxycycline-inducible lineage tracing system. Such a significant contribution from non-b-cells was also evident after multiparity or high-fat diet-induced obesity. Labeling other pancreatic cells with the doxycycline system identified the glucagon-producing a-cell as a predominant source of b-cell transdifferentiation in the cases of post-apoptosis regeneration and multiparity. In contrast, in diet-induced obesity, b-cell conversion contributed to about one fourth of the expanded a-cell pool, explaining the disorganized distribution of a-cells post high-fat diet. In fact, de novo and/or trans-differentiation were active mechanisms to replenish acells. We failed to detect any acinar-to-b-cell trans-differentiation.
Ectopic expression of Nkx6.1, a key transcription factor for b-cell differentiation [24] and identity [25] , promotes a-cell transdifferentiation and systemic insulin production. Here, we provide comprehensive and highly quantitative measurements of the autonomous contributions from multiple pancreatic cell types to the adult bcell pool upon different metabolic challenges. Our results suggest that adult b-cells preferentially originate from cells with relatively small developmental distance and high pre-existing abundance, and the relative contribution can be changed by metabolic insults or pharmacological interventions. We demonstrate the general usefulness of our lineage tracing system for the comprehensive and quantitative analysis of pancreatic cell fate and for the development of regenerative therapies.
MATERIALS AND METHODS

Mice
The transgenic mouse strains MIP-CreER T2 , MIP-rtTA, PPG-rtTA [26] , and TRE-Nkx6.1 were generated and recently characterized by our laboratory. The transgene constructs were generated by subcloning the coding DNA sequence (CDS) into a plasmid containing the promoter: MIP-CreER T2 , the 1983-bp CreER T2 CDS following a 8.3-kb mouse insulin 1 promoter; MIP-rtTA, the 747-bp rtTA.M2 CDS following a 8.3-kb mouse insulin 1 promoter; PPG-rtTA, the 747-bp rtTA.M2 CDS following a 1.7-kb mouse preproglucagon promoter; TRE-Nkx6.1, the 1098-bp golden hamster Nkx6.1 CDS following a 0.3-kb TRE-tight promoter. The PANIC-ATTAC transgenic mouse was generated by our laboratory as previously described [22] . The mouse strains TRE-Cre (#006234), RIP-rtTA (#008250), Rosa26-LacZ (Rosa26-loxP-STOP-loxP-LacZ, #003474), Rosa26-Tomato (Rosa26-loxP-STOP-loxP-tdTomato Ai9, #007909), and Ptf1a-rtTA (#018070) were purchased from the Jackson Laboratory. All mice were bred in the C57BL/6 genetic background. Mice were fed on regular (LabDiet #5058), high-fat (60%, Research #D12492), or doxycycline chow diet (600 mg/kg, Bio-Serv #S4107). Mice were maintained in 12-h dark/ light cycles, with ad libitum access to diet and water. All protocols for mouse use and euthanasia were reviewed and approved by the Institutional Animal Care and Use Committee of the University of Texas Southwestern Medical Center.
Genotyping PCR
Approximately 3 mm of mouse tail tip was incubated in 80 mL 50 mM NaOH at 95 C for 1.5 h. 8 mL 1 M TriseHCl (pH 8.0) was added for neutralization. After vortexing and a short spin down, 0.5e1 mL of supernatant was used as PCR template. Primer sequences for genotyping PCR are listed in Table S1 . The PCR program was: 95 C for 5 min, followed by 35 cycles of 95 C for 15 s, 62 C for 30 s, and 72 C for 30 s, and ended with 72 C for 3 min.
Tamoxifen administration
A 25-mg tamoxifen citrate pellet with a release time of 21 days (Innovative Research #E-351) was implanted subcutaneously, and the mice were housed individually during the release period.
Dimerizer administration
Mice were subjected to one intraperitoneal injection of the dimerizer AP20187 (Clontech #635059) at the dose of 0.3e0.5 mg/g body weight/day. The dimerizer stock solution was stored at À80 C, and freshly diluted in 2% Tween-20 with 10% polyethylene glycol 400 before injection.
Multiparity
Adult female mice were mated to be pregnant at least three times and sacrificed for pancreas paraffin sections during the last pregnancy, at around 15.5 days post-coitus.
b-gal staining
Mice were subjected to isoflurane anesthesia and cardiac perfusion of 0.2% glutaraldehyde in PBS (10e15 mL per mouse). Tissues were immediately dissected, transferred to 20-mL scintillation vials with 0.2% glutaraldehyde in PBS, and minced into 1e3 mm wide slices. Tissue slices were washed with rinse buffer (0.1 M sodium phosphate, 2 mM MgCl 2 , 0.01% sodium deoxycholate, and 0.02% NP-40, pH 7.3) three times for 30 min and incubated with X-gal staining buffer (1 g/L Xgalactoside, 5 mM K 3 [Fe(CN) 6 ], and 5 mM K 4 [Fe(CN) 6 ] in rinse buffer) in the dark, at room temperature, with shaking at 100 rpm, for 24 h. Tissues slices were then fixed in 10% formalin overnight and briefly rinsed three times with 50% ethanol. In the University of Texas Southwestern Medical Center Molecular Pathology Core, tissue slices were embedded in paraffin blocks, and the sections were counterstained with Nuclear Fast Red. Bright field images were acquired on a Nikon Coolscope digital microscope or an Olympus FSX100 all-in-one microscope.
Immunohistochemistry
Mouse tissues were collected and processed for paraffin sections as previously described [23] . Primary antibodies and dilution for immunostaining or immunofluorescence were: b-galactosidase ( 
RT-qPCR on pancreatic islets
Mouse pancreatic islets of Langerhans were isolated as previously described [23] . Total RNA was extracted with an RNeasy Mini kit (Qiagen #74106). cDNA was synthesized with a SuperScript II reverse transcriptase (Invitrogen # 18064-014) plus the RNaseOUT recombinant ribonuclease inhibitor (Invitrogen # 10777-019). Quantitative realtime PCR (qPCR) was performed with the Power SYBR Green PCR master mix (Applied Biosystems # 4368708) on a 7900HT Fast RealTime PCR System (Applied Biosystems # 4329001). Primer sequences for qPCR are listed in Table S2 .
Glucose tolerance test
Mice were fasted for 4e6 h and subjected to an oral gavage of dextrose (2 mg/g body weight). Tail blood was collected at 0, 15, 60, and 120 min, prepared for plasma, and assayed for glucose and insulin.
Data analysis
Immunofluorescence-stained cell numbers, as well as islet areas, were quantitated with ImageJ. Cell percentages in individual islets were presented as bubble charts, with the bubble size proportional to the denominator cell number. For an individual mouse, every cell population was summed from all the examined islets respectively, and calculated for percentages. The area under curve (AUC) in tolerance tests was calculated for individual mouse by the trapezoidal method. Two-tailed student's t-test was applied for all paired and unpaired comparisons. Statistical significance was accepted at P < 0.05. and immunofluorescence ( Figure S1A ). At this point, the labeled mice carrying the PANIC-ATTAC transgene were subjected to dimerizerinduced b-cell apoptosis, followed by two months of autonomous regeneration. Consistent with our previous report [22] , the b-cell ablation was evident by hyperglycemia two weeks after dimerizer administration, and a significant decrease in blood glucose 10 weeks post dimerizer as the result of the recovery of b-cell mass ( Figure S1B ). In the regenerated islets, there was no apparent evidence of b-cells originating from any precursors other than b-cells ( Figure 1B ). Tamoxifen has a prolonged activity in CreER T2 nuclear translocation, which may confound the results of lineage tracing experiments [16, 17] . To establish a time point when the b-cells are functionally free of tamoxifen activity, we examined the subcellular location of the CreER T2 protein by immunofluorescence ( Figure 1C ). Importantly, the nuclear CreER T2 signal was sustained beyond the 1-week washout period and became undetectable after 4 months of washout. At this point, the labeled islet cells remained mostly b-gal þ ( Figure 1D ).
To quantitatively trace the origins of autonomously regenerated bcells, we employed another reporter, tdTomato, and generated the To improve the temporal control in lineage tracing experiments, we employed the doxycycline-inducible gene expression system ("TetOn"). We created a MIP-rtTA transgenic mouse strain, which showed no activity in tissues ( Figure S2 ) other than pancreatic b-cells [26] and We utilized the Tet-On system to trace the lineages of adult b-cells upon other metabolic challenges ( Figure 2C , D and E). We allowed female mice to undergo at least 3 pregnancies, which implements cycles of b-cell hyperplasia and apoptosis at low frequency [27] . Under these conditions, about 11 AE 4% of insulin þ cells were Tomato À , i.e. multiparous female mice display slightly more than one in ten b-cells that originate from non-b-cells. In male mice, after 15 weeks of highfat diet-induced obesity ( Figure S3B ), we detected a 9 AE 1% contri- S3D ). This process was significant only after the ATTAC challenge (3.3 AE 0.9% versus 0.12 AE 0.09% in controls, P ¼ 0.02), and no significant change was observed in the cases of multiparity or dietinduced obesity. We further investigated whether these former bcells trans-differentiate into glucagon-producing a-cells in the islets ( Figure 3A) . The Tomato þ glucagon þ cells accounted for <3% of the
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Tomato-tagged cells ( Figures 3B and S4A) , consistent with the Tomato þ insulin À population ( Figure 2F ). However, they composed 25 AE 3% of the a-cell pool after the challenge with diet-induced obesity, but not upon exposure to the ATTAC treatment or multiparity ( Figures 3C and S4B ). This finding suggests the chronic bcell hyperplasia induces active b-to-a conversion and provides an explanation for the disorganized a-cell distribution in obese mouse islets. and [MIP-rtTA; TRE-Cre; Rosa26-Tomato; PANIC-ATTAC] mice were subjected to 1-week of doxycycline diet and 1-week washout. Subsequently, mice were subjected to no challenge, an ATTAC challenge, multiple pregnancies, or high-fat diet-induced obesity. (C) X-gal (blue) staining of pancreas from the Rosa26-LacZ mice. Scale bars: 50 mm ("no challenge" and "ATTAC") or 100 mm ("multiparity" and "high-fat diet"). conversion. In multiparous females, the Tomato þ insulin þ /insulin þ cell ratio was also prominently increased to 13.0 AE 0.9% (P ¼ 0.001).
However, the obese males ( Figure S7C ) did not show a significant ato-b conversion (6 AE 2%, P ¼ 0.4), consistent with the active reverse b-to-a conversion under high-fat diet ( Figures 3C and S4B ).
Assuming the reporter expression did not affect cell fates, an increase in the Tomato À glucagon þ /glucagon þ cell ratio would suggest a replenishment of a-cells through de novo or trans-differentiation. Such trends were indeed observed in all the challenged groups, most significantly in the multiparous females ( Figure S8 ). In the case of dietinduced obesity, b-cell trans-differentiation contributed to one fourth of the a-cell pool, which represents a major source of the newly differentiated a-cells (Figures 3C and S4B) . All of the post-challenge Subsequently, mice were subjected to no challenge, an ATTAC challenge, multiparity, or diet-induced obesity. The ATTAC-challenged mice were examined at 10 or 5 weeks after dimerizer administration as indicated. Pancreas sections were subjected to immunofluorescence of tdTomato (red) and insulin (green). Top panels: Tomato signal only. Bottom panels: Tomato merged with insulin and DAPI (blue). Arrowheads: Tomato and DAPI (blue) signals. The nuclear Cre signal is co-localized with DAPI (purple). Scale bar: 100 mm. (C) [Ptf1a-rtTA; TRE-Cre; Rosa26-LacZ; PANIC-ATTAC] mice were subjected to 1-week of doxycycline diet and 1-week washout. Subsequently, mice were subjected to no challenge, an ATTAC challenge, multiparity, or diet-induced obesity. Pancreas were subjected to X-gal (blue) staining and processed for paraffin sections. Scale bars: 50 mm ("no challenge" and "ATTAC") or 100 mm ("multiparity" and "high-fat diet"). (D) A kinetic model of adult b-cell generation. The contribution of certain cell type to the b-cell pool depends on its number and "differentiation barrier". Self-replication of pre-existing b-cells is the most readily approach, and is the predominant source unless b-cells are extremely ablated [7] . As the second abundant endocrine cell type in the islet, a-cell can contribute significantly upon b-cell loss, presumably by switching on/off some key transcription factors. Conversely, b-to-a conversion is active during chronic b-cell hyperplasia, e.g. in dietinduced obesity. Differentiation from endocrine d-cells [8] , endogenous progenitors [4] , or ductal cells [3] were observed before adulthood or with certain induction, due to the limited number or developmental distance. As the most abundant pancreatic cell type, the exocrine acinar cell has a great potential in artificially induced b-trans-differentiation [10, 11] , but its autonomous conversion is rare in adulthood [28, 29] . depends on the population size of the precursor cells. Like the concentration of chemical reactants, the more abundant a precursor cell type is, the more it contributes to the progeny population. Hence, b-cell self-replication [23, 32, 33] plays a predominant role unless the original population of mature b-cells is depleted to an extreme extent (>99%) [7, 8] or with irreversibly impaired viability [19] . In the setting of moderate (70e85% in PAINC-ATTAC, data not shown) or repeated (multiparity) b-cell apoptosis, a-cells stand out from the other non-b endocrine cells due to their relative abundance [34] . Their conversion can be induced by genetic manipulation of transcription factors [12, 13, 15] or a tumor suppressor [14] . The contributions from d-cells [8] , Ngn3 þ endogenous progenitor cells [4] , and ductal cells [3, 13] are context-dependent or hardly detectable, because of their limited number and/or more distantly-related genetic programs. Considering the very large population size, acinar cells could be a potent target for induced conversion [10, 11] , but, in the models used here, there is no detectable contribution to the b-cell pool under any circumstances.
When the b-cell population is chronically enriched, e.g. during dietinduced obesity, the process drives the reverse conversion into a-cells.
Nkx6.1 promotes a-to-b trans-differentiation
A validation of this model can be to decrease the barriers of cell conversion to examine whether such steps can promote transdifferentiation. Since the a-cell is the major precursor of adult b-cell regeneration post apoptosis in our PANIC-ATTAC mouse, we investigated whether this process can be promoted by overexpression of a key transcription factor for b-cell differentiation, such as Nkx6.1. This is a transcription factor that plays a key role in maintaining identity and function of the b-cell [24, 25, 35] . We generated a TRE-Nkx6.1 transgenic mouse that enabled us to take advantage of doxycyclineinducible overexpression in adults. When crossed with the RIP-rtTA transgenic mouse, the exogenous Nkx6.1 is overexpressed and functional in pancreatic islets, as demonstrated by moderately increased expression of insulin and cell cycle regulators such as Cdk2 ( Figure S10A ). After doxycycline treatment on the [Ptf1a-rtTA; TRENkx6.1] mice, ectopic expression of Nkx6.1 emerged in a majority of pancreatic acinar cells, and showed a conspicuous nuclear localization ( Figure S10B ). We also detected nuclear Nkx6.1 in glucagon þ islet cells of the doxycycline-treated [PPG-rtTA; TRE-Nkx6.1] mice, though at a lower proportion ( Figure S10C ). In the [Ptf1a-rtTA; TRE-Nkx6.1] mice, we did not detect any amylase PANIC-ATTAC] mice and subjected them to dimerizer administration. These hyperglycemic mice also showed a significant increase in the glucagon þ insulin þ /glucagon þ cell ratio compared to the [PPG-rtTA;
PANIC-ATTAC] controls (P ¼ 0.01), and the fold change was similar to the unchallenged group ( Figures 6A and S12) . Interestingly, the glucagon þ cell proportion in the pancreatic islets significantly increased in the groups post b-cell ablation ( Figure S13 ). Hence there were more glucagon þ insulin þ cells per unit area of the islets ( Figure S14 ).
To evaluate if the ectopic Nkx6.1-promoted a-to-b cell conversion can improve insulin production, we performed oral glucose tolerance test. In both the unchallenged ( Figure 6B , C, D) and ATTAC-challenged (Figure 6E , F, G) groups, the in vivo glucose-stimulated insulin secretion was significantly increased in the Nkx-6.1-overexpressing mice, but not in the control cohort. Although this increase was not sufficient to improve glucose tolerance ( Figure S15 ), it provides evidence, in principle, that the trans-differentiated b-cells are functional.
Collectively, our results suggest that ectopic expression of Nkx6.1 can promote b-cell conversion in a-cells but not in exocrine acinar cells. This forced a-to-b conversion improves insulin production and release in both normal and diabetic mice.
DISCUSSION
The tamoxifen-inducible Cre/loxP system was almost exclusively used in the previous lineage tracing studies for the insulin-producing bcells. While these experiments were very elegant and state-of-the-art at the time, they may have provided somewhat misleading results. In experiments labeling pre-existing b-cells, no evidence of a non-b-cell contribution to adult b-cell regeneration was observed when the washout period between the tamoxifen pulse and the turnover chase was short, such as less than 1 week [1, 2] . However, such evidence was more easily found when the washout period was extended to months [6] . Powers and colleagues reported tamoxifen-driven nuclear translocation of Cre recombinase lasting beyond 1 month in b-cells [16] . We recently demonstrated a prolonged presence of residual tamoxifen in adipocyte lineage tracing experiments, leading to artifacts [17] . In previous studies Such contributions are also evident in mice after multiple pregnancies,
i.e. cycles of b-cell hyperplasia and apoptosis [27] , as well as dietinduced obesity, although to a lesser extent. Labeling the glucagonproducing a-cell in the pulse stage reveals it to be a major source of the newly differentiated b-cells in the cases of ATTAC regeneration and multiparity. Of note, our results do not exclude minor contributions from other differentiated cell types [3, 8] or endogenous progenitors [4] .
Conversely, we observe no b-cell conversion from the exocrine acinar cells in adult mice, in line with previous reports [28, 29] . However, this can be seen at a significant degree by cytokine treatment [11] or transcriptional manipulation [10] . In fact, our results support a "kinetic" model for b-cell replenishment as an analogy to the kinetic theory of chemical reactions [30] . The stochastic models of microscopic reactant particles/precursor cells suggest their reaction/conversion kinetics depends on both their abundance and the energy/ developmental barriers. The more developmentally related cells are more readily used: first, self-replication; and second, transdifferentiation from related cell types, such as the endocrine a-cells or d-cells [8] . The less related cell types, e.g. the exocrine acinar cells, make minimal contributions.
We provide the first, precise characterization of the contribution of acells to the cell-autonomous processes of adult b-cell turnover, which is supported with direct lineage tracing evidence. As the two most abundant cell types in the endocrine pancreatic islets, adult a-cells and b-cells have the plasticity to compensate for each other under specific metabolic conditions. The progressive a-to-b conversion is a predominant mechanism of the limited b-cell regeneration in adult mice subjected to diphtheria toxin-induced, extreme b-cell loss (>99%) and kept alive by insulin treatment [7, 8] . In this setting, the initial b-cell population was ablated too much to make a significant contribution. Similarly, b-cells with irreversible loss of TIF-IA fail to survive or proliferate and solicit non-b-cells as the primary source of regeneration [19] . Artificial induction of a-to-b conversion can be achieved by overexpression of Pax4 [12, 13] or Pdx1 [15] in progenitor cells or a-cells, as well as endocrine tumorigenesis [14] . Other studies support the a-to-b mechanism with observations of glucagon þ insulin þ bihormonal cells [5, 19] . In the PANIC-ATTAC model with more moderate b-cell ablation followed by autonomous regeneration without any exogenous support or interference, the remnant b- On the other hand, we provide proof of principle that ectopic expression of Nkx6.1 in a-cells can promote a-to-b conversion and improve insulin production in adult mice. In contrast, no trans-differentiation was observed in the exocrine acinar cells with forced expression of Nkx6.1. Compared to the high frequency of Nkx6.1 þ but absence of insulin þ acinar cells, the relatively rare Nkx6.1 þ glucagon þ and insulin þ glucagon þ cells on the pancreas section may suggest a rapid conversion of identity and/or an a-cell-specific suppression on Nkx6.1.
The underlying mechanisms, such as whether this conversion is reversible, and whether it triggers new a-cell generation, remain to be studied. Alternatively, an overexpression cocktail of Nkx6.1 and other b-cell transcription factors, such as Pdx1 [15] , MafA, and NeuroD, may further potentiate the a-to-b conversion. Interestingly, in b-cell-ablated mice, the ectopic Nkx6.1 drives the trans-differentiation at a similar percentage to a-cells as in the euglycemic mice. However, the bihormonal cell population increases along with the increased a-cell population. It further highlights the clinical potential for a-to-b conversion, considering the much higher proportion of a-cells in human islets [36] . The Tet-On system for lineage tracing of pancreatic cells has multiple advantages. First, based on the similar labeling efficiency (w100%), prompt (<1 week) and complete washout of doxycycline-driven Cre expression grants much better temporal control than the tamoxifen system. Second, administration of the water-soluble doxycycline produces fewer side effects than that of the oil-based tamoxifen, which triggers an acute lipoatrophy [17] and chronic lesions [16] . These side effects can be especially confounding in mouse models with impaired b-cells or other metabolic disorders. Third, specific cell types can be labeled by adopting an appropriate promoter-driven rtTA transgene.
We have successfully labeled the b-cell, a-cell, and pancreatic acinar cell. Other cell types such as pancreatic ductal cells, endocrine d-cells, PP cells, ε-cells, and endogenous progenitor cells can be targeted and studied for their potential to emerge as b-cells. In fact, this system can also be used to validate new rtTA transgenic strains. Fourth, it can be adapted to other reporters, e.g. mTmG and HPAP, and facilitate the quantitation of different cell populations. Last but not least, this system can be readily subjected to various physiological/pathological conditions, or induction of differentiation, and studied for the developmental mechanisms.
CONCLUSIONS
In summary, we establish an efficient and adaptable lineage tracing system for pancreatic cells, quantitatively identify the sources of adult b-cells under multiple metabolic conditions, and propose a kinetic model of cell conversion. Our data also reconcile the discrepant findings generated by the tamoxifen-inducible system.
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